Systemic therapies for intrahepatic cholangiocarcinoma.

Kelley RK, Bridgewater J, Gores GJ, Zhu AX. Systemic therapies for intrahepatic cholangiocarcinoma. J Hepatol. 2020 02; 72(2):353-363.

View in: PubMed

subject areas

Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Bile Duct Neoplasms
Chemotherapy, Adjuvant
Cholangiocarcinoma
Humans
Immunotherapy
Incidence
Molecular Targeted Therapy
Treatment Outcome
Tumor Microenvironment

authors with profiles

Robin Kelley

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement